Charles E. Cooley

Array ( [id] => 6306434 [patent_doc_number] => 20100069303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'METHODS OF TREATING BONE DISEASE USING VASCULAR ENDOTHELIAL GROWTH FACTOR FUSION CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 12/552103 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 24378 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069303.pdf [firstpage_image] =>[orig_patent_app_number] => 12552103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994524 [patent_doc_number] => 08518406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)' [patent_app_type] => utility [patent_app_number] => 12/544319 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 19180 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12544319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373702 [patent_doc_number] => 20090311263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'HUMAN VASCULAR IBP-LIKE GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 12/544413 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13037 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311263.pdf [firstpage_image] =>[orig_patent_app_number] => 12544413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870311 [patent_doc_number] => 08895508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particles' [patent_app_type] => utility [patent_app_number] => 13/386844 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 6697 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992527 [patent_doc_number] => 20110014180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Preparations for tissue restoration containing atrial diuretic hormone and family molecules as active ingredients; method of restoring tissue using the preparation; agents for growing, restoring, promoting growth of hair and agents for promoting restoration of skin tissue and cardiac muscle tissue containing atrial diuretic hormone family molecules as active ingredients; method of growing, restoring, promoting growth of hair by using the agents; and method of promoting restoration of skin tissue and cardiac muscle tissue' [patent_app_type] => utility [patent_app_number] => 12/460308 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7625 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014180.pdf [firstpage_image] =>[orig_patent_app_number] => 12460308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368427 [patent_doc_number] => 20090305986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'FGF21 Mutants and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/455610 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 90 [patent_no_of_words] => 32310 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305986.pdf [firstpage_image] =>[orig_patent_app_number] => 12455610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367148 [patent_doc_number] => 20090304707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'MONOCLONAL ANTIBODIES TO BASIC FIBROBLAST GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 12/474198 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10530 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304707.pdf [firstpage_image] =>[orig_patent_app_number] => 12474198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000623 [patent_doc_number] => 20110117065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR USING CELLS TO TREAT HEART TISSUE' [patent_app_type] => utility [patent_app_number] => 12/994626 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8919 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117065.pdf [firstpage_image] =>[orig_patent_app_number] => 12994626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6091070 [patent_doc_number] => 20110218332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/436773 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 44985 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218332.pdf [firstpage_image] =>[orig_patent_app_number] => 12436773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6120878 [patent_doc_number] => 20110077206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'USE OF HNF4ALPHA FOR TREATMENT OF HUMAN MALIGNANT SOLID TUMORS THROUGH INDUCTION-DIFFERENTIATION THERAPY' [patent_app_type] => utility [patent_app_number] => 12/921369 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8583 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077206.pdf [firstpage_image] =>[orig_patent_app_number] => 12921369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398614 [patent_doc_number] => 20090318677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/427410 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20862 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318677.pdf [firstpage_image] =>[orig_patent_app_number] => 12427410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614166 [patent_doc_number] => 20100099601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'FIBRILLATION-RESISTANT INSULIN AND INSULIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/419169 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12918 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099601.pdf [firstpage_image] =>[orig_patent_app_number] => 12419169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212808 [patent_doc_number] => 20110136108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'XBP1(S) Protein Acting as an Adipocyte Differentiation Marker Having a Facility to Regulate Differentiation into Adipocytes, and an Application Therefor' [patent_app_type] => utility [patent_app_number] => 12/936168 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 9383 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136108.pdf [firstpage_image] =>[orig_patent_app_number] => 12936168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196941 [patent_doc_number] => 20110028699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Agent for Treating Skin Aging and Scars' [patent_app_type] => utility [patent_app_number] => 12/934299 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5833 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028699.pdf [firstpage_image] =>[orig_patent_app_number] => 12934299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993751 [patent_doc_number] => 20110015345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Modified FGF-23 Polypeptides and Their Uses' [patent_app_type] => utility [patent_app_number] => 12/922679 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 110110 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015345.pdf [firstpage_image] =>[orig_patent_app_number] => 12922679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404451 [patent_doc_number] => 20090239765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'GENES WHOSE EXPRESSION IS INCREASED IN RESPONSE TO STIMULATION BY CORTICOTROPIN-RELEASING HORMONE' [patent_app_type] => utility [patent_app_number] => 12/404010 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21649 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239765.pdf [firstpage_image] =>[orig_patent_app_number] => 12404010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202852 [patent_doc_number] => 20110065638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'NOVEL CRUSTACEAN ANDROGENIC GLAND HORMONE' [patent_app_type] => utility [patent_app_number] => 12/736048 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3277 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065638.pdf [firstpage_image] =>[orig_patent_app_number] => 12736048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4569955 [patent_doc_number] => 07858584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Angiogenically effective unit dose of FGF and method of administering' [patent_app_type] => utility [patent_app_number] => 12/391956 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14403 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858584.pdf [firstpage_image] =>[orig_patent_app_number] => 12391956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404487 [patent_doc_number] => 20090239801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Modified Fusion Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/389022 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5298 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239801.pdf [firstpage_image] =>[orig_patent_app_number] => 12389022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7503510 [patent_doc_number] => 08034772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Inhibitor of vascular endothelial cell growth factor' [patent_app_type] => utility [patent_app_number] => 12/322800 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 9733 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034772.pdf [firstpage_image] =>[orig_patent_app_number] => 12322800 [rel_patent_id] =>[rel_patent_doc_number] =>)